The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Becotatug vedotin vs. chemotherapy in pre-heavily treated advanced nasopharyngeal carcinoma: A randomized, controlled, multicenter, open-label study.
 
Fei Han
No Relationships to Disclose
 
XiaoHui Wang
No Relationships to Disclose
 
Yanqun Xiang
No Relationships to Disclose
 
Lin-Quan Tang
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Xiaolei Shu
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Sufang Qiu
No Relationships to Disclose
 
Yujuan Zhou
No Relationships to Disclose
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD
 
Guiqiong Xu
No Relationships to Disclose
 
Kunyu Yang
No Relationships to Disclose
 
Jingao Li
No Relationships to Disclose
 
Mingjun Xu
No Relationships to Disclose
 
Fenghua Wang
No Relationships to Disclose
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Hutchison MediPharma; Junshi Pharmaceuticals; Keymed Biosience; MSD; QiLu Pharmaceutical